Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03394664 · ClinicalTrials.gov registry record · NA
FB4 (Framingham, Boston, Bloomington, Birmingham, and Baylor)
A NA study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT03394664: Clinical Trial NA study, sponsored by Boston Children's Hospital.
NCT03394664 is a NA study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03394664, a NA study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
This study will evaluate the effects of dietary carbohydrate and sugar consumption, independent of energy content, on body fatness and metabolism in a rigorous feeding study.
Primary Outcome
Body composition assessed using a multi-component model
Interventions
- BEHAVIORAL Feeding Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2018-05-09 |
| Est. Completion | 2020-05-03 |
| Phase | NA |
Why NCT03394664 stopped before completion
NCT03394664 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Feeding Study is the first listed.
NCT03394664 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03394664 about?
NCT03394664 is a clinical study titled "FB4 (Framingham, Boston, Bloomington, Birmingham, and Baylor)". This study will evaluate the effects of dietary carbohydrate and sugar consumption, independent of energy content, on body fatness and metabolism in a rigorous feeding study.
What is the current status of trial NCT03394664?
This trial is currently terminated. It is a NA study. The enrollment target is 166 participants. The study started on 2018-05-09. Estimated completion is 2020-05-03.
What interventions are being tested in trial NCT03394664?
The interventions under investigation include: Feeding Study (BEHAVIORAL).
Who is sponsoring clinical trial NCT03394664?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03394664's enrollment target sits among peer trials
166 625th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI